Literature DB >> 1312894

Cytogenetic findings in three primary hepatocellular carcinomas.

G Bardi1, B Johansson, N Pandis, S Heim, N Mandahl, A Andrén-Sandberg, I Hägerstrand, F Mitelman.   

Abstract

Short-term cultures of three primary hepatocellular carcinomas were cytogenetically analyzed. Case 1 displayed a normal karyotype. Case 2 had, in addition to cells with a normal male chromosome complement, a clone with -Y. In case 3, two abnormal clones were found, one with -Y and one with a highly aberrant karyotype: [formula: see text] Our results, collated with the findings in one previously published primary hepatocellular carcinoma and in three cell lines, suggest that structural changes of chromosomes 1 and 6, leading to loss of 1p and 6q material, and loss of chromosome 16 are frequent events in hepatocellular carcinogenesis.

Entities:  

Mesh:

Year:  1992        PMID: 1312894     DOI: 10.1016/0165-4608(92)90111-k

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  Standardised fluorescence in situ hybridisation in cytological and histological specimens.

Authors:  Ludwig Wilkens; Heidrun Gerr; Dorothea Gadzicki; Hans Kreipe; Brigitte Schlegelberger
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

2.  Expression of proliferation associated antigens and detection of numerical chromosome aberrations in primary human liver tumours: relevance to tumour characteristics and prognosis.

Authors:  M Nolte; M Werner; A Nasarek; H Bektas; R von Wasielewski; J Klempnauer; A Georgii
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

3.  Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.

Authors:  N Wong; W C Lam; P B Lai; E Pang; W Y Lau; P J Johnson
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma.

Authors:  L Wilkens; M Bredt; P Flemming; Y Schwarze; T Becker; M Mengel; R von Wasielewski; J Klempnauer; H Kreipe
Journal:  J Mol Diagn       Date:  2001-05       Impact factor: 5.568

5.  Cytogenetic analyses of secondary liver tumors reveal significant differences in genomic imbalances between primary and metastatic colon carcinomas.

Authors:  L A Parada; A Marañon; M Hallén; K G Tranberg; U Stenram; G Bardi; B Johansson
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

6.  Investigation of chromosomal aberrations in Egyptian hepatocellular carcinoma patients by fluorescence in situ hybridization.

Authors:  Magdy S Aly; Abeer A Bahnassy; Zekri N Abdel-Rahman
Journal:  Indian J Hum Genet       Date:  2010-05

7.  Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study.

Authors:  A Nasarek; M Werner; M Nolte; J Klempnauer; A Georgii
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.

Authors:  N Wong; P Lai; S W Lee; S Fan; E Pang; C T Liew; Z Sheng; J W Lau; P J Johnson
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

9.  New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.

Authors:  J Tian; Z Y Tang; S L Ye; Y K Liu; Z Y Lin; J Chen; Q Xue
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.